Man Group’s Melinta Therapeutics MLNT Stock Holding History
Bought
Maintained
Sold
Other funds holding MLNT
OH
Man Group's MLNT Position: Q2 2018 in Review
Man Group sold out of Melinta Therapeutics (MLNT) in Q2 2018, closing a stake of 30,708 shares — an estimated $1.14M sold.
Man Group first reported a position in MLNT in Q1 2018 and held it in 1 quarter. The position peaked at $1.14M in Q1 2018. 87 funds tracked by Wall St. Rank hold MLNT as of Q2 2018.
- Man Group reported no remaining Melinta Therapeutics position as of Q2 2018 after selling out during the quarter.
- Man Group sold 30,708 Melinta Therapeutics shares in Q2 2018, an estimated $1.14M.
- Man Group first reported a position in Melinta Therapeutics in Q1 2018 and held it in 1 quarter.
- Man Group's Melinta Therapeutics position peaked at $1.14M in Q1 2018.
- 87 funds tracked by Wall St. Rank held Melinta Therapeutics as of Q2 2018.
Based on Man Group's 13F filing for Q2 2018, filed 14 Aug 2018.